搜索临床试验以:利妥昔单抗生物类似药
总计3567个结果
-
University of Turin, ItalyAzienda Ospedaliera Città della Salute e della Scienza di Torino招聘中
-
Fifth Affiliated Hospital, Sun Yat-Sen University未知
-
University Hospital, GhentMerck Sharp & Dohme LLC完全的
-
Genentech, Inc.完全的
-
Sofia Perea, Director Clinical Trials Unit.未知
-
University of CagliariAzienda Ospedaliero Universitaria di Cagliari招聘中
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)完全的
-
Stanford University完全的
-
Universitaire Ziekenhuizen KU LeuvenMerck KGaA, Darmstadt, Germany完全的
-
GOG FoundationNational Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)终止
-
Shanghai Ninth People's Hospital Affiliated to...招聘中
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)完全的
-
Memorial Sloan Kettering Cancer CenterEli Lilly and Company; National Comprehensive Cancer Network完全的
-
Gynecologic Oncology GroupBristol-Myers Squibb; National Cancer Institute (NCI)完全的
-
Centre Hospitalier of ChartresHospital of Chartres- France完全的
-
Roswell Park Cancer InstituteCelgene完全的
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)撤销
-
National Cancer Institute (NCI)NRG Oncology主动,不招人复发性乳腺癌 | HER2/Neu阳性 | 孕激素受体阳性 | IA 期乳腺癌 AJCC v7 | IB 期乳腺癌 AJCC v7 | IIA 期乳腺癌 AJCC v6 和 v7 | IIB 期乳腺癌 AJCC v6 和 v7 | IIIA 期乳腺癌 AJCC v7 | IIIC 期乳腺癌 AJCC v7美国, 加拿大, 波多黎各, 爱尔兰
-
Shanghai Ninth People's Hospital Affiliated to...招聘中
-
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...招聘中
-
Heidelberg UniversityMerck KGaA, Darmstadt, Germany; University Hospital Heidelberg; Dept. of Radiation Oncology, INF...未知
-
Institute of Hematology & Blood Diseases HospitalHenan Cancer Hospital; Nantong University; Tianjin Medical University Second Hospital; The First... 和其他合作者未知
-
University of ArizonaNational Cancer Institute (NCI)完全的
-
Hoffmann-La Roche终止类风湿关节炎法国, 德国, 瑞士, 英国, 西班牙, 荷兰, 希腊, 波兰
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的卵巢子宫内膜样腺癌 | 卵巢浆液性癌 | 卵巢未分化癌 | 输卵管癌 | 卵巢透明细胞腺癌 | 卵巢粘液腺癌 | 输卵管移行细胞癌 | 卵巢移行细胞癌 | 输卵管透明细胞腺癌 | 输卵管子宫内膜样腺癌 | 输卵管粘液腺癌 | 输卵管浆液性腺癌 | 输卵管未分化癌 | 恶性卵巢布伦纳瘤 | 卵巢浆液性腺癌 | 原发性腹膜浆液性腺癌 | 原发性腹膜癌 | FIGO III 期卵巢癌 | FIGO IIIA 期卵巢癌 | FIGO IIIA1 期卵巢癌 | FIGO IIIA2期卵巢癌 | FIGO IIIB 期卵巢癌 | FIGO IIIC 期卵巢癌 | FIGO IVA 期卵巢癌 | FIGO IVB 期卵巢癌 | FIGO IIIA1(i) 期卵巢癌 | FIGO IIIA1(ii) 期卵巢癌美国
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的晚期恶性实体瘤 | 复发性乳腺癌 | 雌激素受体阳性 | HER2/Neu阳性 | 孕激素受体阳性 | IV 期乳腺癌 AJCC v6 和 v7 | 绝经后 | IIIA 期乳腺癌 AJCC v7 | IIIB 期乳腺癌 AJCC v7 | IIIC 期乳腺癌 AJCC v7 | 难治性乳腺癌 | 绝经前 | 难治性激素受体阳性乳腺癌美国
-
The First Affiliated Hospital with Nanjing Medical...未知
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)完全的
-
University of Wisconsin, MadisonGenentech, Inc.; Celgene Corporation撤销
-
Grupo Español de Linfomas y Transplante Autólogo...完全的
-
Groupe Oncologie Radiotherapie Tete et CouGustave Roussy, Cancer Campus, Grand Paris完全的